Prevention & Chronic Conditions

Broadcast

e-SPACE CRM 2026 – Day Two

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

Broadcast

e-SPACE CRM 2026 – Day One

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

COVID-19 Pandemic and Cardiovascular Disease

Published:

25 March 2020

Citation:

US Cardiology Review 2020;14:e01.

Ivabradine and AF: Coincidence, Correlation or a New Treatment?

Published:

11 February 2020

Citation:

Arrhythmia & Electrophysiology Review 2019;8(4):300–3.

Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure

Published:

07 February 2020

Citation:

US Cardiology Review 2019;13(2):83–7.

Testosterone and the Heart

Published:

11 July 2019

Citation:

European Cardiology Review 2019;14(2):103–10